Literature DB >> 18929731

Fracture risk in very young women using combined oral contraceptives.

Peter Vestergaard1, Lars Rejnmark, Leif Mosekilde.   

Abstract

BACKGROUND: Little is known on fracture risk in young women using oral contraceptives. STUDY
DESIGN: Case-control study (64,548 cases, 193,641 controls).
RESULTS: Overall, no major association with risk of fracture was present. Only in a few age groups a limited increase (OR 1.1-1.5) was seen in those using low average doses (less than one tablet per day - i.e., intermittent use). Neither 20 nor >or=30 mcg per day of ethinylestradiol was associated with risk of fractures, while changing from 20 to >or=30 mcg per day or vice versa was associated with a limited increase in fracture risk (OR 1.1-1.4) in some age groups.
CONCLUSIONS: In general, use of oral contraceptives in young women did not seem to be associated with an increased risk of fractures. The isolated increase seen in some strata with low average doses may be linked to factors associated with discontinuation of oral contraceptives rather than pharmacological effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929731     DOI: 10.1016/j.contraception.2008.06.010

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  7 in total

1.  Oral contraceptive use and bone density in adolescent and young adult women.

Authors:  Delia Scholes; Laura Ichikawa; Andrea Z LaCroix; Leslie Spangler; Jeannette M Beasley; Susan Reed; Susan M Ott
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

2.  Recent advances in hormonal contraception.

Authors:  Hw Raymond Li; Richard A Anderson
Journal:  F1000 Med Rep       Date:  2010-08-09

3.  Short-term jump activity on bone metabolism in female college-aged nonathletes.

Authors:  Kohei Kishimoto; Ryan P Lynch; Jamie Reiger; Vanessa R Yingling
Journal:  J Sports Sci Med       Date:  2012-03-01       Impact factor: 2.988

Review 4.  Steroidal contraceptives and bone fractures in women: evidence from observational studies.

Authors:  Laureen M Lopez; Mario Chen; Sarah Mullins Long; Kathryn M Curtis; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2015-07-21

5.  Hormonally Active Contraceptives Part I: Risks Acknowledged and Unacknowledged.

Authors:  William V Williams; Joel Brind; Laura Haynes; Michael D Manhart; Hanna Klaus; Angela Lanfranchi; Gerard Migeon; Mike Gaskins; Elvis I Seman; Lester Ruppersberger; Kathleen M Raviele
Journal:  Linacre Q       Date:  2021-01-27

6.  Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year period.

Authors:  Talita Poli Biason; Tamara Beres Lederer Goldberg; Cilmery Suemi Kurokawa; Maria Regina Moretto; Altamir Santos Teixeira; Hélio Rubens de Carvalho Nunes
Journal:  BMC Endocr Disord       Date:  2015-04-03       Impact factor: 2.763

7.  Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.

Authors:  Duru Shah; Madhuri Patil
Journal:  J Hum Reprod Sci       Date:  2018 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.